Overview

Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol Therapy

Status:
Completed

Trial end date:
2007-11-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to better understand the influence of insulin resistance upon treatment response in hepatitis C virus treated with PEG Intron and Rebetol.

Phase:

Phase 4

Details

Lead Sponsor:

Louisiana State University Health Sciences Center in New Orleans

Collaborator:

Schering-Plough

Treatments:

Interferon-alpha
Peginterferon alfa-2b
Ribavirin